Valeant stock collapses 47% over major business woes

March 16, 2016
Valeant Pharmaceuticals warned on Tuesday it faces a default risk if it fails to file a key report by April 29. The drug maker also said the cancellation of its controversial price hikes is hurting its business.
Read more at:http://rss.cnn.com/c/35493/f/676943/s/4e4832ae/sc/24/l/0Lmoney0Bcnn0N0C20A160C0A30C150Cinvesting0Cvaleant0Estock0Eplunge0Edefault0Ewarning0Cindex0Bhtml0Dsection0Fmoney0Itopstories/story01.htm

Site Created by finaceandbankingnewsnow.com